GENE EXPRESSION PROFILES ASSOCIATED WITH ASTHMA EXACERBATION ATTACKS

The present invention provides methods for the assessment, diagnosis, or prognosis of asthma exacerbation, by assessing the level of expression of asthma exacerbation gene products in a sample derived from a patient. The markers of the present invention can be used in methods to identify or evaluate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HILL, ANDREW, ARTHUR, REDDY, PADMALATHA, SUNKARA, SILVER, MATTHEW, REN, IMMERMANN, FREDERICK, WILLIAM, O'TOOLE, MARGOT, MARY, LIU, WEI, CSIMMA, CRISTINA, ILEANA, CHAUDHARY, DIVYA, DORNER, ANDREW, JOSEPH, MCKEE, CHARLOTTE, MARIE, RYAN, JOHN, LOUIS
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention provides methods for the assessment, diagnosis, or prognosis of asthma exacerbation, by assessing the level of expression of asthma exacerbation gene products in a sample derived from a patient. The markers of the present invention can be used in methods to identify or evaluate agents capable of modulating marker expression levels in subjects with asthma. La présente invention concerne des procédés pour l'évaluation, le diagnostic ou le pronostic d'une exacerbation de l'asthme, par l'évaluation du niveau d'expression de produits géniques d'exacerbation de l'asthme dans un échantillon provenant d'un patient. Les marqueurs de la présente invention peuvent être utilisés dans des procédés pour identifier ou évaluer des agents capables de moduler des niveaux d'expression de marqueurs chez des sujets atteints d'asthme.